trial · primary record
CLL-1, CD33 and/or CD123-specific CAR gene-engineered T cells
Acute Myeloid Leukemia
| Phase | Phase 1, Phase 2 |
|---|---|
| Status | TERMINATED |
| Sponsor | Unknown |
| Enrolment | 10 |
| Primary completion | 2026-07-31 |
| Primary endpoint | Safety of infusion |
| Registry ID | NCT04010877 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-11-02T15:44:54.835Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT04010877
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.